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~ A  Prospective Evaluation of the Outpatient Initiation 
of Antlarrhylhmic Therapy for Supreventricular 
Tachyarthythmlas 
Roger J, Laham, Ma~k E. Jasephscn. Harvard MediCal School, Beth Israel 
Hospital, Boston, MA 
This study was designed to ievealigate the foa~ibil~end safety of the out- 
patient Initiation of antianhythmic therapy in Pts with Supraventrl~lar tash- 
yarfhythmlas (SVT). Pts with SVT that required treatment with antiarrhytmic 
drugs were eligible for enrollmeoL Pls with active coronary artery disease, 
previous MI, CHF, LVEF < 40%, ventri~tar tacl~yanttythmias, prolonged QT, 
end une~¢plalned syncope were excluded from the study. The starting dose 
was edministered and Pts were obsen~rd for 2 hours. Using transtelaphonic 
monitoring, ECG stripe were transmitted 2 hours after each dose and with 
any symptoms, Pts were followed for 1 month, An identical cohort, hospi- 
talized for the initiation of identical antiarrhythmi~ drugs, was identified and 
constituted the comDarison population, The study cohort consisted of 28 Pts 
413 men and 15 women). The mean age was 58 ~ 19 years (range 20-86 
years). 2 Pts ('/%) had mild systolic left venfricutsr dysfunction end 2 Pts 
(7%) had estabfialted coronary artery disease. 5 Pis 418%) had LVH. The 
index ar~ythmia was atrial fibrillation in 21 patients (75%). The entiarrhyth- 
mio drags used were amlodarone in 11 Pts (39%)° tiecalnide in 9 Pts (32%), 
sotalal in 4 Pts (14%), dlsopyramide in 3 Pts (11%), and procalnamlda in 1 
Pt (4=/0), On follow-up, the average minimal heart rate was 58 ~: 9 Bpm. Only 
2 patients had QT intewal prolongation which did not lead to discontinuation 
of therapy. Complete suppression of index arrhythmia was observed in 12 
patients 443%). Adverse events were seen in 2 (7%) Pts (5-beat vanfficular 
tachycerdia~nrenotrOpic in ompetence) and resolved with discontinuation 
of therapy. The comparison cohort consisted of 28 patients (15 men and 
13 women, mean age 62 :E 18 years, atrial fibrillation in 75% of Pts). The 
mean hospital stay was 3,2 :E 1.1 days. The mean hospital charges of the 
hospitalized patients were significantly higher than the outpatient population 
charges 4T~6,586 -v 2,190 vs $1,173 :E 1,912, p < 0,0001). Conclusion:This 
study demonstrates that the outpatient initiation of antiarrhythmic therapy for 
SVT may provide s safe and cheaper alternative to the hospitalization of 
these patients for that puq~ose. 
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~ Long-Term Fellow-Up in Patients With Medically 
~elraetory Atrial Fibrillation Treated W'dh 
Propafenone and S~talol 
Leonard I. Ganz, Julie B, ehea, Sharon C. Reimold, Catherine O, Centillion, 
Peter I_ Friedman, IEIliott M. Antman. Brigharn and Women's Hos/~ital, 
Boston, MA 
Between March 1985 and August 1991, 209 patients who had failed to 
respond to an average of two type IA antiarrhythmi¢ drugs for atrial tibfillalion 
or flutter 4AF) were enrolled in investigational protocols utilizing propatecone 
(PPFN) end sotolal (SOT). Their msan age was 62 years and meen ejection 
fraction was 58%. AF was paroxysmal in 49% and chronic in 51%. Structural 
heart disease was present in 85%; 15% were Ions fibdllators, A survey 
regarding vital stair,s, current medications, and rhythm status was conducted 
after a mean follow, up of 5,3 years (range, 2`8-9,0 yearn), To date, vi~ status 
is known in 144 patients 469%). Total mo~dity duflng follow-Up iS 11,5%. 
Cardiac dlythm and medication information is available on f13 patier~, 
Recurrent symptomstio AF (either ,'hronio or paroxysmal) is now present in 
80 patients (71%), 
Cunent Therapy Re~urmnt AF(n = 80) Sinus Rhythm (n = 33) 
PPFN or SOT 16 24 
Ar~odarone 5 7 
Warfarin 73 t3 
Permanent pacemakers were implanted in 7 patients prior to enrollment 
and in 2,3 since enrollment. Thus, in the Ior~toml follow-up of this cohort 
of medically ~ r y  AF patients: 1. Mortality is abo~ 2,2% per year. 2. 
AF recurs frequently ~ fre&lmeot with PPFN and SOT, 3, AKdarrhyth- 
mic therapy does not eliminate the use of Ior@term warfadn therapy. 4. 
Permanent ~cemakers are t~mn~y imp~ed ~n these pa~ents. 
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~ Clinical Significance of a Non-High*Risk Ischemic 
SPECT Scan Within 6 Months After FrCA 
Timothy M. Bate~an, James H. O'Keofe Jr., James R McGraw, C~rie 
~, BamharL Robert W. Ugon. Cardiovascular Consultants, RC., Mid 
America Heart InsfitOte, Kansas City, MO 
Nonischsmi¢ SPECT s,~-~s po~t PTCA w~dk,"t a Im'~ !i~!ih~:l for subse- 
quem cardiac events while extensively isehemic scans usually prompt further 
revasCularizatien. Currently, it is unknown whether pts with non-extensive re- 
VerSible perfusion defects (NERPDs [defined as < 1 of LAD or multivessel 
distribution iscbemia or abn, TI-20t lung uptake]) within the first 6 rues post- 
PTCA have a benign outcome as do pts with NERPDs and non-intervened 
CAD. TO evaluate this, we analyzed our experience with all such SPECT 
findings from 1989 to 1994. Of 697 pts with NERPDs _.< 6 mos post-PTCA 
(1% lost to follow.up): 81% were male; 58% had prior MI; 20% had prior 
CA~]G; 52% had angina and 90°/<= had single-vesSel d]sthbu~on ischemia. 
There were 51 hard events (14 c~ndtac deaths; 37 nonfatal MIs) during a 
mean f/u of 30 mos; freedom from events was ¢, = at one year, 93% at two 
years, and 92% at three yearn. The only significant correlate of a hard event 
was repeat PTCA (event rate 10.6% vs 5.3% for those treated me~cally). 
P|S treated with repeat PTCA (n = 291) were compared to those treated 
medically (n = 400): the only significant difference was that 58"1o f repeat 
PTCA pts had angina vs 48% of medically Ireated pts (p = 0.009). 
Conclusions: 1) PIS with NERPDs ~ 6 rues post-PTCA have a significant 
hard event rate over the next few years; 2) Pts who have events am not easily 
predicted by usual Clinical indices; and 3) Responding to a non-extensive 
reversible pertusion defect on SPECT by further PTCA doubles the hard 
event rate. 
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~ l*123Hodophenylpentadecanoic Acid (IPPA) 
Overestimates Myocardial Salvage Early After 
Reperfusion 
David K. Glover, Mirta Ruiz, Hiwot Desta, Dennis A. C, alnon, William 
H. Smith, Denny O. Watson, George A. Belier, University of Virginia, 
CharlotP..swlle, VA 
We have prcvious~ .~ho~'n IPPA to be supedor to T1-201 for assessing 
i~yocardial v;abii~ in a canine ~ Of sgSt~ined low flOW end systolic dys- 
function with minimal subendosardial necrosis. We now sought o determine 
the potential use of IPPA for assessing myocardial viability eady after roper- 
fusion (Rp), Accordingly, IPPA (5 mCi) was injected in 5 dog~ 60 rain alter 
Rp following 180 rain of total LAD occlusion (O¢c) and images were acquired 
over 2 hours. LAO Thickening fell from 21 to -3% (p < 0.01) during Occ and 
remained dyskine~c after Rp, Despite an infarct size averaging 50.6% of the 
dsk area (13,9% LV) them waS subslantial IPPA uptake seen on initial im- 
ages, LAD/LGX count ratios from background sul0~ected images were 0.64 
"4- 0.03 and 0.76 ~: 0.03 at 5 artd 120 rain respecSvely (p = NS). In addition, 
the transmurel LAD/LCX IPPA activity ra~o from post mortem gamma well 
counting (0,82) was not significantly different from the Rp LAD/LCX flow ratio 
when IPPA was injected (1.0). Even in the most severely ischami¢ segments 
(Oc¢ flow < 10% nom~al; n= 45), there was substentJal IPPA activity of 63,6% 
of normal suggesting sequestration of no~l i zed  Iracer. In summary, 
in this canine model of coronary Oct and Rp, e~,rly administration of IPPA 
resulted in an overestimation of the ~ of myocan~al salvage due to 
retentiOn of the tracer in infarcted regions. The mechenism for this prolonged 
retention remaln~ to be datem~ined. 
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~ Rekltion of Preoperative Ischemia Severity to 
A~ts~e/~Di~a~ Greffing In 2"vessel COronary 
Phyllis G. Supine, Clare Hod-.'ea~, DeboP~ A. Lauterstein, Ben A. D~i, 
,~flrey S. Borer. Comell ~ coerce, New York, IVY 
We have previously sP, ovm that ischenda severity, determined by change 
44) in LVEF Imm rest to exar~ex)  during ra~onLcJide cineangiography 
(~RNC, A), iS art i n ~  ~ of ~ events (CE) among reed'tally 
treated (MEO) 10ts ~ 2-veasal(v) oarena~y ane~ ¢~seese (CAD). HOwever. 
U~e beeatits ot com~ =te,y bypass ~dt~g4CABG) for th~ Ix~at~n(pop) 
45A ABSTRACTS-Oral JACC February 1996 
are controversial and the ability of preop iechemia severity to predict, events 
after CABG has not been defined. Accordingly. we followed 47 consecutive 
clinically stable MED pts with angiegreghiceffy documented 2.v CAD who 
previously had undergone rest and ex RNCA and compared their course 
with a parallel group of 37 consecutive pte who ul~le~ent CABG alter 
RNCA without known intercorrent ischemtc evanL All pts had LVEF ~ 30% 
at rest. Dudng av 10 4. 4 yr followup, initial CE included 7 deaths (CD) 
and 7 nonfatal myocardial infamtiol~s (MI) among MED tots vs 1 CD and 5 
MI among those with CABG, For the entire pop, CABG tended to cause a 
decrease in CD (p < 0,06 vs MED). However, this finding masked important 
subgroup differences: in pts whose LVEF fell 5% or more from rest to ex 
(& LVEF < -5%), CABG significantly improved suwival (ev annual CD dek 
[AAR]:0.6%[CABG] vs 4.0%[MED|, p < 0.04). In contrast, CABG produced 
no eun~hral benefit among pts with no or less severe is~hemta (~ LVEF > 
-5%), all of whom remained free of CD irrespective of treatment. CABG also 
tended to reduce total CE rates (including MI) for pts with pmop 6, LVEF <_ 
-5% (AAR:2.2%[CASG] vs 6,3%[MED], p = 0,07), but am~ng pts with A LVEF 
> -5%, CABG had no impaot on CE (AAR:l.4%[CABG,MED],NS). Thus, 
preop ischemia severity predicts CABG,mediated prolongation of su~val 
and event reduction in pts with 2-v CAD. Determination of iechemia may 
inform selection of pts with 2*v CAD for CABG. 
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~ Direct Comparison of  FDG SPECT With 
Stress-RslnJe~ion Thallium SPECT and Dobutamine 
Echocardlography for Predicting Regional 
Improvement A, '~r Revascularizatio~ 
Jan H. Cornel, Jemen J. Bax, Frans C. Visser, Peele M. Fioretti. University 
Hospital Rotterdam and Free University Hospital Amsterdam, The 
Netherlands 
The aim was to compare 3 techniques to predict functional outcome after 
revasculadzation (R). Seventeen patients (mean EF 38 d: 115',,) with chronic 
coronary artery disease (CAD) were studied prior to surgical R, Regional 
function was evaluated before and 3 months after R by echo (13-segment 
model). Regional FDG uptake (during hypednsulinemic glucose damp) was 
compared with resting perfusion assessed with early 1"1-201 (TI) SPECT. All 
SPECT data were analyzed quantitatively. On FDG SPECT, viability was 
defined as normal parfusion or m!_~match (:> 7% increased FDG ugtake 
relative to TI). For TI stress.reinjection, viability was defined when there was 
normal uptake, (partially) reversible uptake or L.m3J.,ePsible mild fixed uptake 
(> 50% of normal activity). Dyssynergic segments were cunsidered viable 
on echo in presence of improved wall thickening dudog dobutamine (10 
pg/kg/min) infusion. Improvement Of regional function wa.~ obsewed in 27 of 
92 successfully R segments. 
FDG T~.relnj DE 
se.s/~p~. (%) __ sen~/sp~c(%) ....... Sf~n~Vspec(%) . . . .  
All seom 89177 93143 8S/63 
Akinet~ 78/90 78169 67193 
H mo~.e~c s4/s7 ~0o/~ 9~/~9 ............ 
Logistic regression showed that in akinetic esgment~ FDG was the best 
predictor for recovery and that in hypokinetic segments the combination of 
FDG and DE yielded the most a~cerate prediction for functional n~,~overy. 
Integration of metabolic and functional data is necessary, particularly in 
hypokicesia, for the optimal prediction of improvement of regional function in 
patients with GAD. 
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Coronary Vasodllatory Capacity end Row Reserve 
-- Ate Attenuated In Normal MyocBrdlum Supplied by 
Bypass Grafts 
Roxena C, ampisi, Johannes Ccemfn, Harold L, Kal~man, Heinrich 
R. Schalbert. UCLA School of Medicine, Los Angeles, CA 
Invesive studies demonstrated a normal or attenuated fl~w velodty increases 
in patent bypass grafts (CABG) in response to pha~:Ologic vasodilation. 
However, the hyperenlic flow response of normal ~ ium SUbtended 
by CABG has not been studied. AlSo, it is unknown if pharmacologic va- 
sodilation evokes cor~arel~e hyperemi¢ responses in artedal arKI venous 
CABG. Therefore, myacerdi~l bl0ed tiow (MBF) and flow resen~ (FR) were 
quan~ed = rest and ~dng d~idamole hyperemla in normal rny~ium 
(po~r map ana~ts) ~ ~ ~a l  (n ,, 10) and v~s  CABG (n = is) 
in 14 Pabents (66 4. 8 years) at 8 4- 4 yearn attar suqileqf with N.13 angnania 
and PET. Tan ItealthY ~ (62 4- 6 ysa~) senred as controls. Rate 
preasum I~doots (flPP) were ~ in patients and ~i*-ots at blmlMe 
(~1 + l~J,~ ve 7686 • 22~2) aed duting d l~d~e (10118 ± 2S~ ~ 
10424 ~ 1799; p = N:S). Accordingly, MBF at rest did not differ (0.65 ~: 0,16 
vs 0.68 4. 0.16 ml/g/mln; p = NS) and was correlated to RPP in both groups 
(y = 8.07E - 5x + 0.02; r = 0.6G; p = 0.01 and y = 11090.28x + 75.2; r = 0.77; 
p < 0.02), The hyperemi¢ MBF response in normal myocardium supplied by 
CABG was less than in controls (1.62 4. 0.33 vs 2.02 4. 0.32 ml/g/roin; p < 
0.0t ). H.~Peremlc MBF was similar in normal royoca~ium supplied by arterial 
and venous grafts (1.65 ~: 0.29 vs 1.62 ~ 0.35 ml/g/min; p = NS). The similar 
resting MBF together with the blunted hyperemic response resulted in a lower 
FR in normal myoca~iuro supplied by CABG than in controls (2,54 4. 0,49 vs 
3.12 d: 0.86 mr/g/mira p < 0,05). Thus, the coronary vasodilatory cepacity is 
impaired to a similar degree in normally pertused myocardEum subtended by 
arterial and venous grafts, possibly due to proliferation of vascular smooth 
muscle cells ~ intimal thickening altering smooth mue~le cell relaxation 
in response to dipyridamole. Further, an impairment in flow mediated, an. 
dothelium dependent coronary vasodilation might contribute to the impaired 
hyperemio response. 
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Assessment of Coronary Flow Rsserve After Stent 
Implantation Using Positron Emission Tomogtephy 
Istvan Kosa, Rudolf Blasini, Jan Schneider-Eioke, Timm IDickfald, Franz 
J. Neumann, SibyUe Ziegler, Albert Sch/tmtg, Markus Schwaignr. IM 
Oepatlment of Internal Medicine and Nudear Medicine, Technische 
Universit~t MOnchen, Germany 
Numerous stress perfusion studies have demonstrated that coronary angio- 
plasty despite successful dilation of a flow-limiting stenosis falls to normalize 
comnan/flow reserve within several days after the intervention. No data are 
available following stent placement at the site of balloon dilatation. In 11 
patients 1,6 4- 0.9 days after coronary stant implantation myoca~isl blood 
flow was measured by N-13 ammonia positron emission temegraphy at rest 
and during adenosin induced maximal vasodilation. The oaronary reserve 
(maximal/basal coronary blood flow) was calculated in regions supplied by 
stented artedes and was compared with that in control regions (CR). All 
patients had single-vessel coronary disease. Four had a history of previous 
myocardial infarction (PMI) with presewed left ventdcular function. At rest, 
coronary flow in the vascular territory (VT) of the stented artery did not differ 
significantly from that in CR (75.0 ~ 13.6 and 73.5 ~ 14.1 ml/min/100 g, 
respectively). At maximal vasodilation, the coronary reserve was at least 
90% of that in CR in 7 of 11 patients (3.2 4- 0.8, corresponding to 130% 4- 
5% of the CR). 3 of the 4 patients showing coronary reserve less than 
of CR had PMI in the stented VT. Repeated coronary ressNe determination 
after 13 days in one of these 3 patients showed no change (73% and 79% Of 
CR, respectively) suggesting a chronic deterioration of vasoragulatiQn due 
to the previous ischemi¢ injury. Thus, most patients without PMI in the VT 
of etented artedes show normalisod cumary reserve within three days after 
complete revascuiatisation with stent impla~,tioo. 
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Automated Diagnosis of Regionel Wall M~tion 
. . . .  Abnomlal i t lss  Using Segmental Analys is  of  
~nd-SystMic Color Klnssis imagos 
Philippe Vignon, Victor Mot-Art, James Bednarz, Lynn Welnert, 
Claudia KOrcerz, David Prater, Rick Koch, Robedo Lang. Unive~ of 
Chicago, ChiC.ago IL 
This study evaluated the accuracy of quanlitative segmental analysis of Color 
Ktnesis (CI 0 image~ to provide objective echecmdiegraphic assessment of 
LV regional wall moUon abnormalities (RWMA). Mel/lods. Echocat~ograms 
were obtained in 40 patients with RWMA's and in 20 normal subjects ErKb 
systolic color maps were divided into se~ using ¢~orn software (fig. 
1). 
